Bluechiip Limited (ASX:BCT) advises that as of Monday, 17 July 2017, the Company has changed its provider for shareholder registry services from BoardRoom Pty Limited to Automic Registry Services.
Bluechiip's unique and patented technology combines secure wireless sample tracking with integrated temperature reading for use in extreme environments, working reliably in temperatures from -196DEG C to +200DEG C, and impervious to autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Based on MEMS technology, the Bluechiip(R) tag contains no electronics. Unlike traditional tracking technology like labels, barcodes or RFID, Bluechiip does not require line-of-sight visibility for temperature readings and tracking, and so can be read through frost without damaging the sample.
The tag can either be embedded or manufactured into storage products such as vials or bags. Easy identification, along with any associated information from the tag can be detected by a reader, which can also sense the temperature of the tagged items. Unlike other tracking methods, the Bluechiip(R) technology can sense the temperature of each item a tag is attached to or embedded in.
This technology is particularly important for industries such as the $2b biopreservation and cryopreservation market, which processes more than 300 million samples per year of tissue, blood, serum, plasma, etc., for industries such as pharmaceuticals, IVF, research and clinical trials. It also has applications in cold chain logistics, food, manufacturing, security and defence.
Further information is available at http://www.bluechiip.com
Bluechiip Ltd (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced that its pro rata 1-for-3 nonrenounceable rights issue at an issue price of $0.028 per ordinary share and its associated Top-Up Facility to raise up to $2.53 million successfully closed on 30 June 2017.
Bluechiip Limited (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, is pleased to provide this company update.
Bluechiip Ltd (ASX:BCT) confirms that the Offer Document, together with personalised entitlement and acceptance form, for the non-renounceable rights issue announced by the Company on 1 June 2017, was sent to all eligible shareholders.
Bluechiip Limited (ASX:BCT) announced to the ASX a non-renounceable rights issue at an issue price of $0.028 per new share.
This Offer Booklet relates to an Offer of New Shares to Eligible Shareholders of Bluechiip Limited (ASX:BCT) by way of a nonrenounceable rights issue. This Offer Booklet is dated 5 June 2017 and was lodged with ASX on that date. The ASX does not take any responsibility for the contents of this Offer Booklet.
Bluechiip Ltd (ASX:BCT) today announced that it is raising up to $2.53 million (before costs) through a pro-rata non-renounceable one for three rights issue of fully paid ordinary shares in Bluechiip to all eligible shareholders holding shares on the record date.
Bluechiip Ltd (ASX:BCT) is pleased to provide the Company's latest Investor Presentation.
Bluechiip Ltd (ASX:BCT) is pleased to provide the script of the Open Briefing interview with the MD/CEO Andrew McLellan.
Bluechiip Ltd (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced it has entered a license and supply agreement with California-based Labcon North America, the world's leading manufacturer of earthfriendly laboratory consumables.